Huajin Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 9
Average round size
info
The average size of a deal this fund participated in
$80M
Portfolio companies 9
Rounds per year 0.30
Lead investments 1
Exits 1
Key employees Soon

Areas of investment

  • Life Science
  • Biopharma
  • Health Care
  • Biotechnology
  • Hardware
Summary

Huajin Capital appeared to be the VC, which was created in 1992. The fund was located in Asia if to be more exact in China. The main office of represented VC is situated in the Zhuhai.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Huajin Capital, startups are often financed by Qiming Venture Partners, IDG Ventures, Highlight Capital. The meaningful sponsors for the fund in investment in the same round are Xunlei, Suning, Qiming Venture Partners.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most successful fund investment fields, there are Virtual Reality, Video. The fund has no exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Suzhou Kintor Pharmaceuticals, Insta360. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2019.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Huajin Capital:
Typical Co-investors
Huajin Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Huajin Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
37 Interactive Entertainment China, Shanghai
42 Ventures Salt Lake City, United States, Utah
BA Ventures -
Broadway Partners Connecticut, Greenwich, United States
Canopy Group Le Sueur, Minnesota, United States
Capital Nature Israel, Tel Aviv, Tel Aviv District
DOCOMO Innovations California, Palo Alto, United States
ECC Capital Beijing, Beijing, China
Global Retail Brands Australia, Melbourne, Victoria
Infema Barcelona, Catalonia, Spain
Modern Capital China, Shanghai
National Skill Development Corporation Delhi, India, New Delhi
Pathfinder Venture Capital Funds Minneapolis, Minnesota, United States
Ririshun Lejia Home Furnishing Trade China, Qingdao Shi, Shandong
Siraj Fund Management Company Area A, Palestinian Territory, West Bank
Suncorp Group Australia, Brisbane, Queensland
TenEleven Ventures Burlingame, California, United States
Xinhe Capital Beijing, Beijing, China
Zhenshun Jijin Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Beilai Bio

$46M15 Apr 2022 Irvine, California, United States

Cygnus Semi

Hardware
Information Technology
Semiconductor
$100M25 Feb 2022 Shanghai, Shanghai, China

Guizhou Core Long March Technology (Marching Power)

Information Technology
Manufacturing
Product Design
Semiconductor
$77M16 Dec 2021 Guiyang, Guizhou, China

Health Care
Medical
Product Research
$60M17 Mar 2021 Nansha District, Guangdong Province, China

MabPlex International

Association
Non Profit
$77M08 Jun 2020 Fremont, California, United States

Biopharma
Biotechnology
Life Science
$278M29 Apr 2020 Shanghai

Suzhou Kintor Pharmaceuticals

Biopharma
Biotechnology
Health Care
Life Science
Pharmaceutical
$45M28 Oct 2019 Jiangsu

Insta360

Consumer Electronics
Photography
Video
Virtual Reality
$30M19 Mar 2019 Futian District, Guangdong Province, China

Das Security

Big Data
Hardware
Security
$7M29 Sep 2017 China, Zhejiang

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Huajin Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: